Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Last Updated: 02/13/17

CTEP Visiting Physician Externship

The Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) sponsors clinical trials of investigational agents or biologic products within its Phase I and Phase II clinical trials networks, as well as through the NCI Clinical Trials Network (NCTN). CTEP welcomes hematology and oncology fellows, senior radiation oncology residents, and junior faculty to become involved in the day-to-day operations of CTEP. Through this up to 4-week experience, visiting physicians will work in close collaboration with CTEP Medical Officers to review comprehensive trial designs, trial implementation, and trial monitoring. Visiting physicians will be asked to sign a confidentiality agreement, and then, will provide review of incoming letters of intent (LOIs) or concepts. They will be present for internal CTEP meetings for the evaluation of new agents or biomarkers, where prioritization of phase I, II, or phase III clinical trials is undertaken. Former visiting fellows and junior faculty have found the experience gained during their rotation to be invaluable for their academic career development by providing them with important insights for the preparation of successful LOIs and the conduct of clinical trials. This experience has also been useful for those choosing to pursue a pharmaceutical or a regulatory career path.

Those who are interested in learning more about the externship may contact Dr. Charles Kunos, charles.kunos@nih.gov, 240-276-6939.